SP-MHCI-0495-3

Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS

US$507.00

In stock

Description

About Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS

The Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O Peptide (IEDB: 43662) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Listeriolysin O Peptide, H-NEKYAQAYPNVS-OH (Uniprot: D2NZ73 aa: 190-201) from JPT is produced under strict quality control and quality management.

Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS - Specifications

  • Peptide sequence: H-NEKYAQAYPNVS-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Infection
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS

References:
Read References with JPT’s Antigen Peptides
Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS has been described in:
Duration of infection and antigen display have minimal influence on the kinetics of the CD4+ T cell response to Listeria monocytogenes infection., J Immunol, 2004 (PMID: 15494519)
Cross-presentation of Listeria monocytogenes-derived CD4 T cell epitopes., J Immunol, 2002 (PMID: 12133966)
High-frequency vaccine-induced CD8⁺ T cells specific for an epitope naturally processed during infection with Mycobacterium tuberculosis do not confer protection., Eur J Immunol, 2014 (PMID: 24677089)

Documentation

Documentation for Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS

Properties

Properties of Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Infection
Layout: Freeze-dried in glass vial
Organism: Listeria
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No, Yes

Further Information to Listeria monocytogenes serotype 1/2a (strain 08-5578) Listeriolysin O 190-201, NEKYAQAYPNVS

Information Values
Sequence: H-NEKYAQAYPNVS-OH
Specifications: 12mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote